Actualité

Gynaecologist, Andrea Bernabeu, receives in New York the Young Investigator Award

  • 23-11-2017

Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos. 

En savoir plus

New IB Newsletter: The answer when everything else fail

  • 23-11-2017

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Instituto Bernabeu deals with the most complex of cases because it has over 30 years' experience that are a guarantee of expert hands at a leading clinic where each case is given personalised treatment. Wasting time is not an option when we are racing against the clock. When the aim of that race is a pregnancy, it is impossible to recover missed opportunities. If a woman's age and the fact that she is not getting pregnant combine, there is only one possible piece of advice: Put yourself in the very best hands and do not leave what quality reproductive medicine can do for you to chance.

En savoir plus

Instituto Bernabeu participation in the V edition of the University of Alicante's Forum on Patent Rights and Biotechnology

  • 22-11-2017

On 24th November, the University of Alicante will hold the V Edition of Patent Rights and Biotechnology Event organised by Magister Lvcentinvs the centre for Master's Degree education in Industrial and Intellectual Property at the University of Alicante.  At the event, university lecturers, lawyers and other experts in the field of biotechnology will cover specific aspects of the legal impact of scientific progress.

En savoir plus

Instituto Bernabeu will present a clinical trial on embryo observation at the National Reproduction Biology Congress in Madrid

  • 22-11-2017

A team of researchers at Instituto Bernabeu has completed a prospective randomised clinical trial aimed at understanding if selection of an embryo generated during a cycle of in vitro fertilisation (IVF) is possible when morphological development is observed just once over the days leading up to transfer. The results of the research work will be presented at the national congress organised by the Association for the Study of Reproduction Biology due to be held in Madrid between 15th and 17th November.

En savoir plus

Ten pieces of Instituto Bernabeu research work included in the Association for the Study of Reproduction Biology (ASEBIR) Congress

  • 15-11-2017

Instituto Bernabeu will once again participate in the Association for the Study of Reproduction Biology (ASEBIR) Congress that is due to be held in Madrid between 15th and 17th November. The reproductive medicine clinic will present ten pieces of research work at the congress. Four of these were produced by the Embryology Unit at Instituto Bernabeu; another by the Egg Donation Unit; and the remaining pieces of work were carried out by the clinic's Molecular Biology and Genetics departments. 

En savoir plus

Dr Bernabeu will present the revolution of anti-mullerian hormone as a contraceptive and a means of delaying ovarian ageing at the Contraception Congress in Albacete

  • 10-11-2017

The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10th and 11th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'

En savoir plus

New IB Newsletter: The Rafael Bernabeu Foundation gives 15,000 euros in scholarships

  • 09-11-2017

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students. The scholarships have a value of 2,500 euros each.

En savoir plus

Instituto Bernabeu researchers discover that chromosome mosaicism can lead to full term pregnancies and healthy children

  • 08-11-2017

Instituto Bernabeu will present a study entitled 'Embryo mosaicism and its impact on the results of cycles of in vitro fertilisation (IVF) and associated factors' at the 19th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR) due to be held in Madrid between 15th and 17th November.

En savoir plus

Recurrent Miscarriages and their multidisciplinary approach to debate in the first regional conferences organized by the Instituto Bernabeu Cartagena at the Universidad Politécnica

  • 03-11-2017

The clinic has promoted a scientific exchange in which prominent specialists from the Region of Murcia participate in a conference that takes place at the Universidad Politécnica of Cartagena on Friday 1st December.

En savoir plus

Research work carried out by Instituto Bernabeu has grabbed the attention of the ASRM Reproductive Medicine Congress

  • 31-10-2017

Instituto Bernabeu will present one of its lines of research work in North America. It will do so at the American Society of Reproductive Medicine Congress (ASRM) due to be held between 28th October and 1st November in San Antonio and the research consists of a clinical trial for improving patient comfort during assisted reproduction treatment. 

En savoir plus

A multidisciplinary team of experts from Instituto Bernabeu, speakers at the opening of the Stem Cell Course at the University of Alicante

  • 27-10-2017

A multidisciplinary team of professionals from Instituto Bernabeu, including Gynaecologists, Biologists, Geneticists, Pharmacists and Embryologists, participates as speakers at the opening of the IV Course on Stem Cells and Clinical Human Embryology, taking place on the 27th October. This is a theoretical-practical course organized by the Biotechnology Department of the University of Alicante.

En savoir plus

The Rafael Bernabeu Foundation gives six university students a helping hand by granting 15,000 euros in scholarships

  • 27-10-2017

Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students.

En savoir plus

Students from the Miguel Hernández University Pharmacy Congress hold an embryology workshop at Instituto Bernabeu in Alicante

  • 26-10-2017

Pharmacy Faculty students are today, Thursday 27th October, participating in an embryology workshop being held at Instituto Bernabeu in Alicante as part of the XIII edition of the Congress of Pharmacy Students organised by the Miguel Hernández University at its San Juan campus.

En savoir plus

The Bar Association of Madrid invites our geneticists to participate in its training event on paternity tests

  • 24-10-2017

The Bar Association of Madrid requested the intervention of expert geneticists from Instituto Bernabeu in its event on paternity tests, a gathering of scientists and lawyers held on 23rd October at the bar association's headquarters.

En savoir plus

The Instituto Bernabeu takes part in the Master’s on Community Pharmacy Direction and Management organised by the UMH

  • 23-10-2017

The Instituto Bernabeu is helping out once again this year in the University Master’s on Community Pharmacy Direction and Management & Optimization of Pharmaceutical Care organised by the Universidad Miguel Hernández (UMH). Doctor Andrea Bernabeu has taken part in this fourth edition that deals with aspects related to pregnancy and maternal-child health with theoretical and practical classes.

En savoir plus

The Instituto Bernabeu and the Chair of Reproductive Medicine from the UA present a study on how nicotine affects sperm at the Histology Congress

  • 19-10-2017

The Instituto Bernabeu and the Chair of Reproductive Medicine of Alicante University (UA) have presented a research project related to smoking and fertility at the 19th Congress of the Spanish Society of Histology and Tissue Engineering, the 4th Ibero-American Congress of Histology and the 7th International Congress of Histology and Tissue Engineering held in Santiago de Compostela.

En savoir plus

The Instituto Bernabeu studies chromosome abnormalities in very young women

  • 18-10-2017

Advanced maternal age is the main factor associated with chromosome abnormalities or aneuploidies in the embryo, which cause problems during the pregnancy and increase the risk of miscarriage. 

En savoir plus

Joint organisation by Instituto Bernabeu and the Association of Pharmacists of Albacete of a course on pharmacotherapy in reproductive medicine

  • 17-10-2017

Together with the Association of Pharmacists of Albacete, Instituto Bernabeu is organising the Pharmacotherapy in Reproductive Medicine course due to be held in the association's conference hall in Albacete. The four-day course will be held on 17th October, 24th October, 7th November and 14th November. 

En savoir plus

Instituto Bernabeu presents the use of a device for reducing the number of injections during ovarian stimulation at the congress held by the Association for the Study of Reproduction Biology

  • 11-10-2017

At the 9th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15th and 17th November, Instituto Bernabeu will present the results obtained when evaluating a new means of administering drugs during ovarian stimulation that reduces the number of injections required. 

En savoir plus

Instituto Bernabeu organizes the meeting "Feel that you love me" to address gynaecological cancer with testimonials and experts

  • 06-10-2017

Sensitive to social causes for years, Instituto Bernabeu has been involved one more year in the awareness month of Breast Cancer. Under the title, "Feel that you love me" Instituto Bernabeu Foundation organizes a day, Tuesday 24th October, to address gynaecological cancer with patient’s testimonies and experts opinions.

En savoir plus

Classic IVF using donated ova improves embryo quality and increases the chances of pregnancy when compared with ICSI in IVF

  • 04-10-2017

Specialists from the Embryology Unit at Instituto Bernabeu will present research work entitled 'Conventional IVF improves the results of an egg donation programme compared with the use of ICSI' at the 9th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15th and 17th November. 

En savoir plus

New IB Newsletter: He will inherit the best of you

  • 28-09-2017

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". In this occasion, to inform you about the Genetic Compatibility Test carried out at Instituto Bernabeu, that allows to detect more than 600 hereditary diseases that we can pass on to our future children.

En savoir plus

New IB Newsletter: COMMITTED TO RESEARCH

  • 22-09-2017

The new Instituto Bernabeu Group newsletter is now available, dedicated to our last reserach work accepted at congress ESHRE 2017.

En savoir plus

Instituto Bernabeu and the University of Alicante, Spain, organise the VI edition of the Master's course in Reproductive Medicine

  • 20-09-2017

For the sixth year in a row, Instituto Bernabeu (IB) and the University of Alicante (UA), through the Reproductive Medicine Professorship, are organising a Master's Course in Reproductive Medicine

En savoir plus

Advances in embryo biopsy techniques: IB workshop for biologists

  • 13-09-2017

As a part of our continuous training programme, an intensive theoretical and practical seminar entitled ‘Advanced Workshop in Embryo Biopsy: Techniques and tips for usage’ will take place next September. The workshop is aimed at reproduction biologists who are specialised in micro-handling techniques.

En savoir plus

The Instituto Bernabeu confirm that embryo cell abnormality detected by next-generation sequencing does not affect birth rates

  • 30-08-2017

The researchers look at the selection that can be made of chromosomally normal embryos with preimplantation genetic screening (PGS) by using the next-generation sequencing (NGS) technique. This leads to an improvement in the results of in-vitro fertilization (IVF) since it detects chromosomally normal embryos, those which are abnormal and also those known as mosaic, which have both normal and abnormal cells. In the case of mosaic embryos, studies show that the abnormal cells are replaced with normal cells and that they may be implanted and are able to develop into a healthy child, although the success rate is somewhat lower.

En savoir plus

A study by the Instituto Bernabeu correlates natural antioxidants with a greater protection of sperm DNA

  • 23-08-2017

The Instituto Bernabeu presents a study on the prevention of DNA fragmentation of sperm, thanks to natural antioxidants, at the international meeting of specialists in reproductive medicine organized by the European Society of Human Reproduction and Embryology (ESHRE).

En savoir plus

The Instituto Bernabeu applies a new technique to detect alterations in sperm production

  • 16-08-2017

Researchers of the Instituto Bernabeu present a study at the meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in Switzerland from 2 to 5 July, in which new techniques are applied to enable more precise detection of sperm production.

En savoir plus

A study by the Instituto Bernabeu detects that immune profile helps detect endometriosis

  • 09-08-2017

The research by the Instituto Bernabeu studies the influence of cytokines, molecules that mediate in immune response with consequences such as inflammation, and which would enable early detection of endometriosis.

En savoir plus

Instituto Bernabeu and the University of Castilla-La Mancha, Spain, organise the II Edition of the Master's course in Male Infertility

  • 03-08-2017

Instituto Bernabeu in Albacete and Alicante (IB), in collaboration with the University of Castilla-La Mancha (UCLM) are organising the second edition of the Master's Course in Male Infertility. 

En savoir plus

New IB Newsletter: Instituto Bernabeu Benidorm. New premises.

  • 27-07-2017

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Our fertility and gynaecology clinic in Benidorm is under renovation, with new facilities and cutting edge technology in order to maintain our high quality, personalised service.

En savoir plus

The Instituto Bernabeu correlates embryo quality with the appearance of mosaicism

  • 26-07-2017

A study by the Instituto Bernabeu has found a correlation between embryo quality and a greater probability of the appearance of mosaicism, the presence of normal cells together with other abnormal cells. For some time, the Instituto Bernabeu has followed different lines of research related to embryo mosaicism and its detection, since these embryos may have lower implantation rates and a greater risk of aneuploidy, a chromosomal abnormality that may lead to genetic disorders.

En savoir plus

An exceptional prick-free blood glucose monitor that gives readings over a mobile device is currently being used at our Endocrinology Unit

  • 20-07-2017

At Instituto Bernabeu, we are an innovative medical centre which applies the latest, cutting edge technologies and techniques to improve our patient's living standards.

En savoir plus

Dr. Joaquin Llacer to represent Spanish doctors at the European Society of Human Reproduction and Embryology until 2020

  • 19-07-2017

Dr. Joaquin Llacer, associate director at Instituto Bernabeu, has been elected to represent all Spanish specialist doctors at the European Society of Human Reproduction and Embryology.

En savoir plus

Instituto Bernabeu's premises in Benidorm are under refurbishment

  • 17-07-2017

Everything is changing in order to ensure that all remains the same. That is, offering a personalised treatment to every patient attending Instituto Bernabeu.

En savoir plus

The way in which the embryo divides during the first two days affects its future chromosome count

  • 12-07-2017

A study by the Instituto Bernabeu selected by the committee of experts of the international meeting of the European Society of Human Reproduction and Embryology, held from 2 to 5 July in Geneva, finds a correlation between the manner in which embryo division takes place and the future chromosome count of the embryo. 

En savoir plus

New IB Newsletter: New examination aimed at testing couples with recurrent implantation failure

  • 06-07-2017

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Instituto Bernabeu leads the new research for the treatment of implantation failure of the embryo and its link with recurrent miscarriage. One of these lines of work is focused on the personalization of the treatment to the specific response of each patient.

En savoir plus

Instituto Bernabeu decreases the number of injections required for ovarian stimulation

  • 05-07-2017

Instituto Bernabeu has revolutionised the way in which drugs for ovarian stimulation are used. Three days' worth of medicine can be taken in a single injection thanks to a device known as the i-Port which is already being used by diabetics. During courses of fertility treatment and when ovarian stimulation lasting an average of ten days is carried out, drugs need to be administered using injections. Many of the women who come to our clinic admit to being afraid of needles.

En savoir plus

Instituto Bernabeu presents eleven items of scientific research at the ESHRE European human reproduction congress.

  • 03-07-2017

The Instituto Bernabeu Group will travel to Switzerland where the reproductive medicine clinic will present eleven pieces of research work carried out by experts at the reproductive medicine clinic. The international scientific committee at the European Society of Human Reproduction and Embryology has selected the research that will be made public during the 33rd edition of the annual congress to be held between 2nd and 5th July in Geneva.

En savoir plus

According to a clinical trial carried out by Instituto Bernabeu, patients prefer injected progesterone over vaginal medication

  • 28-06-2017

Patients undergoing treatment in the egg donation programme and patients undergoing frozen embryo transfer need to be administered progesterone. It is necessary for implantation and for the posterior progress of the pregnancy. Drugs can be administered either by means of a daily subcutaneous injection or vaginally over a period of at least three months. Given that this is a significant period of time, Instituto Bernabeu believes that it is key that the female patient feels at ease if she is to have a good quality of life.

En savoir plus

statistiques de résultats

En savoir plus

Nos résultats de grossesse sont accrédités par des sociétés de certifications externes.

VOUS AVEZ BESOIN D’AIDE ?